The Company's web site is provided as a service only and does not contain all of the official versions of the Company's securities law disclosure documents.
The site is not intended to provide specific investment advice and investors and potential investors are advised to seek professional advice and/or refer to Oncothyreon's official documents filed with the Canadian and United States securities regulatory authorities. The site's contents may not always be the most current source for Company information, although updates will be made frequently. The site is also not intended to provide any security holder of the Company with specific tax advice, nor to provide anyone with specific medical, pharmaceutical or therapeutic advice. A visitor seeking information or advice for the treatment of a cancerous condition should review any information on the site with his or her individual physician or medical practitioner. Software or electronic transmission problems may produce inaccurate or incomplete copies of various documents when downloaded and displayed on a visitor's own computer; therefore, the Company cannot assume responsibility for timeliness, accuracy or completeness of its web site documents. The Company also cannot assume responsibility for the timeliness or accuracy of information in other web sites that are linked to the Oncothyreon web site.
Portions of the Investor section contain forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements, including comments predicting the timing of financings, strategic partnering, regulatory actions, clinical trials or the efficacy of products. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company's expectations are correct. A full discussion of the Company's operations and financial condition, including factors that may affect business and future prospects, is contained in SEDAR documents filed in Canada and documents filed in the United States with the Securities & Exchange Commission on EDGAR or with Nasdaq. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement. This document should not be considered the official disclosure document of the Company.
Although the Company has taken reasonable precautions to prevent unauthorized entry and alterations of its web site, no system is fool proof. Therefore, the Company assumes no responsibility with respect to any computer viruses, destructive programs or unauthorized content that may be inadvertently downloaded from, or purposely inserted into, the web site.
Last posted on December 12, 2005
return to top ^